This clinical commentary discusses the occurrence of drug-induced aseptic meningitis in patients undergoing natalizumab treatment and other immunotherapies.
Keywords: Natalizumab; adverse drug reaction; disease-modifying therapies; drug-induced aseptic meningitis.